These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10088196)

  • 21. Acute volume expansion in normal pregnancy and preeclampsia. Effects on plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) concentrations and feto-maternal circulation.
    Grunewald C; Nisell H; Carlström K; Kublickas M; Randmaa I; Nylund L
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):294-9. PubMed ID: 8160534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Circadian changes of atrial natriuretic peptide, cyclic AMP, cyclic GMP, sodium, blood pressure and heart rate in normal subjects].
    Xu CT; Wang YM
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):37-40. PubMed ID: 1326384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin system.
    Nyström F; Karlberg BE; Ohman KP
    J Hum Hypertens; 1997 May; 11(5):301-6. PubMed ID: 9205937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia.
    Schneider F; Lutun P; Baldauf JJ; Quirin L; Dreyfus M; Ritter J; Tempé JD
    Acta Obstet Gynecol Scand; 1996 Jan; 75(1):40-4. PubMed ID: 8560995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
    Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
    Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
    Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
    Heart; 1996 Aug; 76(2):129-36. PubMed ID: 8795474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial natriuretic peptide and cyclic guanosine-3'5'-monophosphate in hypertensive pregnancy and during nifedipine treatment.
    Manninen A; Vuorinen P; Laippala P; Tuimala R; Vapaatalo H
    Pharmacol Toxicol; 1994 Mar; 74(3):153-7. PubMed ID: 8008721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma atrial natriuretic peptide levels in children with cardiac diseases: correlation with cGMP levels and haemodynamic parameters.
    Weil J; Strom TM; Brangenberg R; Sebening W; Haufe M; Lang RE; Bidlingmaier F; Gerzer R
    Horm Res; 1987; 28(1):64-70. PubMed ID: 2834283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
    Tsutamoto T; Kanamori T; Wada A; Kinoshita M
    J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations.
    Seghaye MC; Duchateau J; Bruniaux J; Demontoux S; Détruit H; Bosson C; Lecronier G; Mokhfi E; Serraf A; Planché C
    Crit Care Med; 1997 Jun; 25(6):1063-70. PubMed ID: 9201062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrepancy between plasma and aortic wall cyclic guanosine monophosphate in an experimental model of congestive heart failure.
    Arnal JF; Hofmann F; Michel JB
    Cardiovasc Res; 1993 Jun; 27(6):1094-100. PubMed ID: 8221770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natriuretic action of ANP is blunted by ACE inhibition in humans.
    Wambach G; Schittenhelm U; Stimpel M; Bönner G; Kaufmann W
    J Cardiovasc Pharmacol; 1989 May; 13(5):748-53. PubMed ID: 2472523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with heart disorders during rest and exercise.
    Szekeres T; Artner-Dworzak E; Puschendorf B; Fritzer M; Havel M; Gassner A; Fridrich L
    Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):69-74. PubMed ID: 8385504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic peptide and parathyroid hormone (1-84) in relation to noradrenaline induced changes in blood pressure in uraemic and healthy subjects.
    Jespersen B; Jensen JD; Brock A; Pedersen EB
    Scand J Urol Nephrol; 1992; 26(3):269-74. PubMed ID: 1332188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological activity of endogenous atrial natriuretic peptide during cardiopulmonary bypass.
    Hayashida N; Chihara S; Kashikie H; Tayama E; Yokose S; Akasu K; Aoyagi S
    Artif Organs; 2000 Oct; 24(10):833-8. PubMed ID: 11091175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.